DermTech (OTC: DMTK)

Some price data may be temporarily unavailable.

KEY DATA POINTS

Current Price

N/A

Daily Change

N/A

Day's Range

N/A

Previous Close

N/A

Open

N/A

Beta

N/A

Volume

N/A

Average Volume

N/A

Sector

Health Care

Market Cap

N/A

Market Cap / Employee

N/A

52wk Range

N/A

Revenue

N/A

Gross Margin

N/A

Dividend Yield

N/A

EPS

N/A

CAPs Rating

N/A

Industry

Biotechnology

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

DermTech Company Info

DermTech's Pigmented Lesion Assay (PLA) offers a noninvasive approach that greatly improves accuracy in detecting early-stage melanoma.

News & Analysis

This Under-the-Radar Stock Has Tripled in 2023 -- and Could Have More Room to Run

This beaten-down healthcare stock has started the new year off with a bang.

Keith Speights | Jan 18, 2023

Will These Two Stocks Boom or Bust?

These two stocks have sky-high potential.

Connor Allen | Sep 7, 2022

Podcast Episodes

3 Healthcare Companies Worth a Look

Swinging for the fences.

Brian Feroldi | Mar 10, 2021

No results found

No transcripts available.

DermTech (OTC: DMTK)

KEY DATA POINTS

DermTech Company Info

News & Analysis

This Under-the-Radar Stock Has Tripled in 2023 -- and Could Have More Room to Run

Will These Two Stocks Boom or Bust?

Should You Sell DermTech and GoodRx Stocks Right Now?

Why DermTech Still Has Ten-Bagger Potential

This Is the Main Problem With DermTech's Q3 Results

3 Stocks to Watch Closely This Earnings Season

3 Things About DermTech That Smart Investors Know

3 Stocks That Could Double Your Money Sooner Than You Think

Podcast Episodes

3 Healthcare Companies Worth a Look

No results found

Premium Investing Services